Deferred Cytoreductive Nephrectomy Following Presurgical Vascular Endothelial Growth Factor Receptor-targeted Therapy in Patients with Primary Metastatic Clear Cell Renal Cell Carcinoma: A Pooled Analysis of Prospective Trial Data.

de Bruijn, Roderick

Deferred Cytoreductive Nephrectomy Following Presurgical Vascular Endothelial Growth Factor Receptor-targeted Therapy in Patients with Primary Metastatic Clear Cell Renal Cell Carcinoma: A Pooled Analysis of Prospective Trial Data. [electronic resource] - European urology oncology 04 2020 - 168-173 p. digital

Publication Type: Journal Article

2588-9311

10.1016/j.euo.2019.12.004 doi


Carcinoma, Renal Cell--drug therapy
Cytoreduction Surgical Procedures--methods
Female
Humans
Kidney Neoplasms--drug therapy
Male
Middle Aged
Neoplasm Metastasis
Nephrectomy--methods
Prospective Studies
Retrospective Studies
Vascular Endothelial Growth Factor A--therapeutic use